Treatment of NOD Diabetes with a Novel Peptide of the hsp60 Molecule Induces Th2-type Antibodies
- 1 August 1997
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 10 (4) , 323-329
- https://doi.org/10.1006/jaut.1997.0150
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The hsp60 Peptide p277 Arrests the Autoimmune Diabetes Induced by the Toxin StreptozotocinDiabetes, 1996
- NOD Mouse Diabetes: The Ubiquitous Mouse Hsp60 is a β-Cell Target Antigen of Autoimmune T CellsJournal of Autoimmunity, 1996
- A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model.Proceedings of the National Academy of Sciences, 1996
- Induction of diabetes in standard mice by immunization with the p277 peptide of a 60‐kDa heat shock proteinEuropean Journal of Immunology, 1995
- Treatment of Autoimmune Diabetes and Insulitis in NOD Mice With Heat Shock Protein 60 Peptide p277Diabetes, 1995
- Insulin-Dependent Diabetes Mellitus as an Autoimmune DiseaseEndocrine Reviews, 1994
- Autoimmune Diabetes Induced by the β-cell Toxin STZ: Immunity to the 60-kDa Heat Shock Protein and to InsulinDiabetes, 1994
- Peptide therapy for diabetes in NOD miceThe Lancet, 1994
- Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein.Proceedings of the National Academy of Sciences, 1991
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989